Blog / Archives
Financial Review of Pure Play Clinical Diagnostic Companies
Who to Watch Among the Pure Play DX Companies? High fliers with cache' among traders and investors: CPHD,EXAS. Value plays for earnings turn-around: ALR, QGEN. Niche companies: NEOG, SQNM....
Emerging Biomarker Diagnostics: BGMD and VRML
Early Stage Diagnostic Players With Novel Biomarkers We posted an overview on Seeking Alpha of two emerging diagnostic companies focused in novel clinical biomarkers which are FDA cleared. Products...
Rayno Life Science Portfolio: Diagnostics and Tools
Here is an update of our Diagnostics and Tools portfolio. Diagnostics and Tools have underperformed the biopharmaceuticals sector over the past 6 months with the exception of the companies acquired....
Rayno Biopharma Portfolio Update: ALXN, BIIB, CBST,REGN, VPHM
We have updated our Rayno Biopharmaceuticals Portfolio with total returns from inception 3/9/09 to 3/30/12. Biggest winners are Alexion (ALXN) Biogen (BIIB) , Cubist (CBST), Regeneron (REGN) and...
Rayno Life Science Portfolio: Alexion (ALXN), Response Genetics (RGDX)
Two Companies With Major Biotech Themes: Orphan Drugs (ALXN) and Targeted Cancer Therapy (RGDX) IBB ($122) Weak Down 1% - 52 Week High of $124 One of our Top Performers in the biopharmaceutical...
No Market Reaction To Supreme Court Patent Rejection For Dx Tests
Diagnostics Stocks Are Relatively Calm After Patent News: But Patents Still Matter The Supreme Court Ruling threw out two process patents on diagnostic tests because they were based on the laws of...
New Trends Or Head Fake: Treasury Yields Up, Gold Down, Equities Rule
There Is A Fork In the Road-Do you Take It? The past two days have shown some very dramatic trends in the market. But we will not discuss the parabolics of AAPL $589 stock up 8% in five days which...
NASDAQ Rolls On To 10 Year High At 3016 Up 1%
Biotech Sector (IBB $119.73) Up 12 % YTD, Lagging NASDAQ (QQQ) Up 17.85% Here is a summary of our recommendations over the past month: No change in our basic Rayno Life Science...
Snow Blog West: Snowy Period by March 17th
All the Models Looking Better for PPT We should see a change by next weekend for one of the worst Sierra seasons in recent times. Mammoth has a good base due to excellent man made snow, but has...
Biotech Stocks Ignited on JNJ Prostate Drug Study
Biotech Sector Recovers from Monday's Weakness-Bull Intact Biotech stocks are strong today tracking a NASDAQ rally and favorable news on JNJ's prostate drug Zytiga which met its goal in a new study....